Further investigations revealed that UDCA inhibited cell proliferation and induced apoptosis through reactive oxygen species-dependent activation of ERK and dephosphorylation of STAT3, synergizing with sorafenib to enhance its inhibitory efficacy on HCC [46]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.